Identification of a murine ICAM-1-specific peptide by subtractive phage library selection on cells

被引:15
作者
Bélizaire, AK
Tchistiakova, L
St-Pierre, Y
Alakhov, V
机构
[1] Supratek Pharma Inc, Laval, PQ, Canada
[2] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada
关键词
ICAM-1; peptide; phage display; antigen presentation;
D O I
10.1016/j.bbrc.2003.08.050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ICAM-I adhesion molecule is expressed selectively at low levels on endothelial cells but is strongly upregulated in dysfunctional endothelial cells associated with inflammation, cancer, and atherogenesis. Using COS-7 cells transfected with murine ICAM-1 (mICAM-1) as a target receptor, a phage display library was screened. Clones were selected by elution with a mAb specific for a functional epitope of ICAM-I and a novel peptide sequence binding to the extracellular domain of mICAM-1 was identified that can potentially be used as a targeting vector aimed at dysfunctional endothelium. We further showed that the targeting specificity of the peptide was retained following its incorporation at the N terminal end of a large chimeric protein. Moreover, this chimeric protein containing the mICAM-1-specific sequence was found to inhibit ICAM-1-mediated intercellular adhesion during antigen presentation. Taken together, these results demonstrate the potential for improving the cell-selectivity and properties of therapeutical agents toward targeting adhesion molecules involved in cell-cell interactions. 2003 Published by Elsevier Inc.
引用
收藏
页码:625 / 630
页数:6
相关论文
共 50 条
[1]   Therapeutic cancer targeting peptides [J].
Aina, OH ;
Sroka, TC ;
Chen, ML ;
Lam, KS .
BIOPOLYMERS, 2002, 66 (03) :184-199
[2]   Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors [J].
Anderson, ME ;
Siahaan, TJ .
PEPTIDES, 2003, 24 (03) :487-501
[3]  
Aoudjit F, 1998, J IMMUNOL, V161, P2333
[4]   Targeting the prostate for destruction through a vascular address [J].
Arap, W ;
Haedicke, W ;
Bernasconi, M ;
Kain, R ;
Rajotte, D ;
Krajewski, S ;
Ellerby, HM ;
Bredesen, DE ;
Pasqualini, R ;
Ruoslahti, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (03) :1527-1531
[5]   Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions [J].
Bo, L ;
Peterson, JW ;
Mork, S ;
Hoffman, PA ;
Gallatin, WM ;
Ransohoff, RM ;
Trapp, BD .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (10) :1060-1072
[6]   ANTIMELANOMA ANTIBODIES FROM MELANOMA PATIENTS IMMUNIZED WITH GENETICALLY-MODIFIED AUTOLOGOUS TUMOR-CELLS - SELECTION OF SPECIFIC ANTIBODIES FROM SINGLE-CHAIN FV FUSION PHAGE LIBRARIES [J].
CAI, XH ;
GAREN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) :6537-6541
[7]  
Champagne B, 1998, J IMMUNOL, V161, P6398
[8]   CD54/ICAM-1 IS A COSTIMULATOR OF NK CELL-MEDIATED CYTOTOXICITY [J].
CHONG, ASF ;
BOUSSY, IA ;
JIANG, XL ;
LAMAS, M ;
GRAF, LH .
CELLULAR IMMUNOLOGY, 1994, 157 (01) :92-105
[9]   Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].
Chung, ES ;
Packer, M ;
Lo, KH ;
Fasanmade, AA ;
Willerson, JT .
CIRCULATION, 2003, 107 (25) :3133-3140
[10]   CELLULAR-DISTRIBUTION OF HUMAN-LEUKOCYTE ADHESION MOLECULE ICAM-3 [J].
CORDELL, JL ;
PULFORD, K ;
TURLEY, H ;
JONES, M ;
MICKLEM, K ;
DOUSSIS, IA ;
TYLER, X ;
MAYNE, K ;
GATTER, KC ;
MASON, DY .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (02) :143-147